We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Johnson and Johnson | NYSE:JNJ | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| -2.10 | -1.41% | 146.43 | 149.58 | 146.33 | 149.37 | 7,642,733 | 00:53:34 |
From Apr 2021 to Apr 2024
By Matt Grossman
Johnson & Johnson Tuesday logged a larger profit in its third quarter, lifted by higher sales in its pharmaceutical, medical-device and consumer-health divisions.
The New Brunswick, N.J.-based pharmaceutical company posted earnings of $1.37 a share, up from $1.33 a share 12 months ago. Net earnings were $3.67 billion, up from $3.55 billion a year earlier.
Stripping out one-time items, the company's adjusted earnings were $2.60 a share. Analysts polled by FactSet had been forecasting adjusted earnings of $2.35 a share.
Sales rose 10.7% to $23.34 billion. Analysts were expecting sales of $23.64 billion.
Pharmaceutical sales rose 13.8%, while medical-device sales were 7.6% higher year over year. Consumer-health sales increased by 5.7%. The segment sales trends exclude the effects of acquisitions and divestitures.
Write to Matt Grossman at matt.grossman@wsj.com
(END) Dow Jones Newswires
October 19, 2021 07:00 ET (11:00 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year Johnson and Johnson Chart |
1 Month Johnson and Johnson Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
